Breaking
Medicus Pharma Ltd. to Present at Biotech Showcase 2026, Advancing SkinJect ProgramEli Lilly's Legal Victory Over Noom's GLP-1 ClaimsBBSW AI Solution Event: Daily Roundup
Friday, June 19, 2026
🇺🇸 FDA

Weight Loss Analysis

🇺🇸 FDA

Expert commentary and market intelligence for pharma strategy teams

Showing 1–3 of 3 articles

Standard impact AnalysisJun 18, 2026

Weight Loss Medications in 2026: GLP-1 Market Shift

FDA · 3 min

Michael Rivera
Medium impact AnalysisMay 30, 2026

Concerns Over GLP-1 Microdoses: A Weight-Loss Doctor's Perspective

GLP-1 · 2 min

Dr. Sarah Mitchell
Medium impact AnalysisMay 21, 2026

Eli Lilly’s Triple-G Drug Achieves Bariatric Surgery-Level Weight Loss

weight loss · 3 min

Dr. Sarah Mitchell

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.